$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Structured bioerodible drug delivery device 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/22
  • A61K-009/50
  • A61K-009/52
  • A61K-009/54
출원번호 US-0517982 (1974-10-25)
발명자 / 주소
  • Michaels Alan S. (Atherton CA)
출원인 / 주소
  • Alza Corporation (Palo Alto CA 02)
인용정보 피인용 횟수 : 105  인용 특허 : 0

초록

A drug delivery device for the continuous and controlled administration of a predetermined therapeutically effective dosage of eye drug to the eye of a mamallian patient over a prolonged period of time. The device meters the flow of polylactic acid polymer micro-encapsulated eye drug by means of a d

대표청구항

A delivery device for the sustained administration of a predetermined dosage of an ophthalmic drug to the eye of a mammalian patient comprising (1) an inner reservoir comprised of a biodegradable material that degrades to innocuous products in response to the biological ocular environment of the pat

이 특허를 인용한 특허 (105)

  1. Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use.
  2. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  3. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  4. Zerangue, Noa; Jandeleit, Bernd; Li, Yunxiao; Gallop, Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  5. Zerangue,Noa; Jandeleit,Bernd; Li,Yunxiao; Gallop,Mark A., Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use.
  6. Gallop, Mark A.; Xu, Feng; Phan, Thu; Dilip, Usha; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  7. Gallop, Mark A.; Xu, Feng; Phan, Thu; Dilip, Usha; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  8. Gallop, Mark A.; Yao, Fenmei; Ludwikow, Maria J.; Phan, Thu; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  9. Gallop, Mark A.; Yao, Fenmei; Ludwikow, Maria J.; Phan, Thu; Peng, Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  10. Gallop,Mark A.; Yao,Fenmei; Ludwikow,Maria J.; Phan,Thu; Peng,Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  11. Gallop,Mark A.; Yao,Fenmei; Ludwikow,Maria J.; Phan,Thu; Peng,Ge, Acyloxyalkyl carbamate prodrugs, methods of synthesis and use.
  12. Gallop,Mark A., Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use.
  13. Gallop, Mark; Cundy, Kenneth C.; Scheuerman, Randall A.; Barrett, Ronald W.; Zerangue, Noa, Amino acid conjugates providing for sustained systemic concentrations of GABA analogues.
  14. Gallop,Mark; Cundy,Kenneth C.; Scheuerman,Randall A.; Barrett,Ronald W.; Zerangue,Noa, Amino acid conjugates providing for sustained systemic concentrations of GABA analogues.
  15. Alster, Yair; de Juan, Jr., Eugene; Reich, Cary J.; Boyd, Stephen; Sierra, David; Alejandro, Jose D.; Macfarlane, K. Angela; Sutton, Douglas, Anterior segment drug delivery.
  16. Alster, Yair; de Juan, Jr., Eugene; Reich, Cary J.; Boyd, Stephen; Sierra, David; Alejandro, Jose D.; Macfarlane, K. Angela; Sutton, Douglas, Anterior segment drug delivery.
  17. Robinson Joseph R. (Madison WI), Bioadhesive compositions and methods of treatment therewith.
  18. Wong Vernon G. (Rockville MD), Biodegradable ocular implants.
  19. Xiang,Jia Ning; Gallop,Mark A.; Cundy,Kenneth C.; Li,Jianhua; Xu,Feng; Zhou,Cindy X.; Bhat,Laxminarayan, Carbidopa prodrugs and derivatives, and compositions and uses thereof.
  20. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q., Catechol protected levodopa diester prodrugs, compositions, and methods of use.
  21. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q., Catechol protected levodopa diester prodrugs, compositions, and methods of use.
  22. Graham ; Jr. Joseph A. (Milo IA) Hibbs Clair R. (Albuquerque NM), Composition for prophylactic treatment of pinkeye.
  23. Castleberry, Steven A.; Hammond, Paula T., Compositions and methods for nucleic acid delivery.
  24. Smith, Renee Chivon; Hammond-Cunningham, Paula T., Controlled delivery of bioactive agents from decomposable films.
  25. Drake Cyril F. (Harlow GBX) Arch Alfred J. (Ongar GBX), Controlled release system.
  26. Leahy, Charles D.; Ellis, Edward J., Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation.
  27. Gupta Suneel K. ; Guinta Diane R. ; Christopher Carol A. ; Saks Samuel R., Dosage form and method for administering drug.
  28. Gardner David L. (Bellville OH), Dual Microcapsules and process for their preparation.
  29. Nun, Joshua Ben, Eye wall anchored fixtures.
  30. Cundy, Kenneth C.; Sastry, Srikonda; Leung, Manshiu; Kadri, Balaji V.; Stach, Paul E., GABA analog prodrug sustained release oral dosage forms.
  31. Cundy, Kenneth C.; Sastry, Srikonda; Leung, Manshiu; Kadri, Balaji V.; Stach, Paul E., GABA analog prodrug sustained release oral dosage forms.
  32. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q., Levodopa dimethyl-substituted diester prodrugs compositions, and methods of use.
  33. Xiang, Jia-Ning; Zhou, Cindy X.; Yao, Fenmei; Nguyen, Mark Q., Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use.
  34. Karaborni, Sami; Leung, Manshiu; Mao, Chen; Thalladi, Venkat, Levodopa prodrug mesylate hydrate.
  35. Karaborni, Sami; Leung, Manshiu; Mao, Chen; Thalladi, Venkat R., Levodopa prodrug mesylate hydrate.
  36. Xiang, Jia Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q., Levodopa prodrug mesylate, compositions thereof, and uses thereof.
  37. Xiang, Jia-Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q., Levodopa prodrug mesylate, compositions thereof, and uses thereof.
  38. Xiang, Jia-Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q., Levodopa prodrug mesylate, compositions thereof, and uses thereof.
  39. Xiang, Jia-Ning; Dai, Xuedong; Zhou, Cindy X.; Li, Jianhua; Nguyen, Mark Q., Levodopa prodrug mesylate, compositions thereof, and uses thereof.
  40. Xiang, Jia Ning; Gallop, Mark A.; Zhou, Cindy X.; Nguyen, Mark; Dai, Xuedong; Li, Jianhua; Cundy, Kenneth C.; Jumbe, Nelson L., Levodopa prodrugs, and compositions and uses thereof.
  41. Xiang, Jia-Ning; Gallop, Mark A.; Zhou, Cindy X.; Nguyen, Mark; Dai, Xuedong; Li, Jianhua; Cundy, Kenneth C.; Jumbe, Nelson L., Levodopa prodrugs, and compositions and uses thereof.
  42. Xiang, Jia-Ning; Gallop, Mark A.; Zhou, Cindy X.; Nguyen, Mark; Dai, Xuedong; Li, Jianhua; Cundy, Kenneth C.; Jumbe, Nelson L., Levodopa prodrugs, and compositions and uses thereof.
  43. Xiang,Jia Ning; Gallop,Mark A.; Zhou,Cindy X.; Nguyen,Mark; Dai,Xuedong; Li,Jianhua; Cundy,Kenneth C., Levodopa prodrugs, and compositions and uses thereof.
  44. Xiang,Jia Ning; Gallop,Mark A.; Zhou,Cindy X.; Nguyen,Mark; Dai,Xuedong; Li,Jianhua; Cundy,Kenneth C.; Jumbe,Nelson L., Levodopa prodrugs, and compositions and uses thereof.
  45. Ellis, Edward J.; Ellis, Jeanne Y., Method for forming an ocular drug delivery device.
  46. Guittard George V. ; Jao Francisco ; Marks Susan M. ; Kidney David J. ; Gumucio Fernando E., Method for the management of incontinence.
  47. Guittard, George V.; Jao, Francisco; Marks, Susan M.; Kidney, David J.; Gumucio, Fernando E., Method for the management of incontinence.
  48. Martins Agusto B. (Palo Alto CA) Amkraut Alfred A. (Palo Alto CA), Method of coadministering an antigen and an immunopotentiator.
  49. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  50. Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  51. Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G., Methods and devices for providing prolonged drug therapy.
  52. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richar, Methods and devices for providing prolonged drug therapy.
  53. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Hatamkhany, Zahedeh; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Weyers, Richard G., Methods and devices for providing prolonged drug therapy.
  54. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D.; Weyers, Richard G.; Gupta, Suneel K.; Guinta, Diane R.; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D.; Hatamkhany, Zah, Methods and devices for providing prolonged drug therapy.
  55. Lam, Andrew C.; Shivanand, Padmaja; Ayer, Atul D; Hatamkhany, Zahedeh; Weyers, Richard G; Gupta, Suneel K.; Guinta, Diane R; Christopher, Carol A.; Saks, Samuel R.; Hamel, Lawrence G.; Wright, Jeri D., Methods and devices for providing prolonged drug therapy.
  56. Yam, Nyomi V.; Reyes, Iran; Davar, Nipun; Ayer, Atul D.; Lee, Julie; Seroff, Sonya; Gupta, Suneel K.; Sathyan, Gayatri, Methods and dosage forms for controlled delivery of paliperidone and risperidone.
  57. Raillard,Stephen P.; Zhou,Cindy X.; Yao,Fenmei; Manthati,Suresh Kumar; Xiang,Jia Ning; Gallop,Mark A., Methods for synthesis of acyloxyalkyl derivatives of GABA analogs.
  58. Raillard,Stephen P.; Zhou,Cindy X.; Yao,Fenmei; Manthati,Suresh Kumar; Xiang,Jia Ning; Gallop,Mark A., Methods for synthesis of acyloxyalkyl derivatives of GABA analogs.
  59. Wood, Kris C.; Chuang, Helen F.; Batten, Robert D.; Lynn, David M.; Hammond Cunningham, Paula T., Methods of making decomposable thin films of polyelectrolytes and uses thereof.
  60. Raillard, Stephen P.; Mann, Adam; Manthati, Suresh K.; Scheuerman, Randall A.; Estrada, Tono; Nguyen, Mark Q.; Zhou, Cindy X, Methods of synthesizing a levodopa ester prodrug.
  61. D'Souza, Martin J., Microencapsulated compounds and method of preparing same.
  62. D'Souza,Martin J., Microencapsulated materials and method of making same.
  63. D'Souza, Martin J., Nanospheres encapsulating bioactive material and method for formulation of nanospheres.
  64. D'Souza, Martin J., Nanospheres encapsulating bioactive material and method for formulation of nanospheres.
  65. Hammond, Paula T.; Lee, Jong Bum; Roh, Young Hoon, Nucleic acid particles, methods and use thereof.
  66. Leahy, Charles D.; Labombard, Denis, Ocular drug delivery device.
  67. Leahy, Charles D.; Labombard, Denis, Ocular drug delivery device.
  68. Leahy, Charles D.; Labombard, Denis, Ocular drug delivery device.
  69. de Juan, Jr., Eugene; Alster, Yair; Reich, Cary J.; MacFarlane, K. Angela; Chang, Janelle; Alejandro, Jose D., Ocular insert apparatus and methods.
  70. de Juan, Jr., Eugene; Alster, Yair; Reich, Cary J.; MacFarlane, K. Angela; Chang, Janelle; Boyd, Stephen; Sierra, David; Alejandro, Jose D.; Sutton, Douglas; Gould, Alexander J., Ocular insert apparatus and methods.
  71. de Juan, Jr., Eugene; Alster, Yair; Reich, Cary J.; Macfarlane, K. Angela; Chang, Janelle; Boyd, Stephen; Sierra, David; Alejandro, Jose D.; Sutton, Douglas; Gould, Alexander J., Ocular insert apparatus and methods.
  72. Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Ocular insert housing steroid in two different therapeutic forms.
  73. Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Ocular preparation housing steroid in two different therapeutic forms.
  74. Cohan Bruce E. ; Diamond Howard, Ophthalmic insert and method for sustained release of medication to the eye.
  75. Rubin, Anne Brody; Alster, Yair; Reich, Cary J., Ophthalmic system for sustained release of drug to eye.
  76. Cundy, Kenneth C.; Gallop, Mark A., Orally administered dosage forms of GABA analog prodrugs having reduced toxicity.
  77. Mao, Chen; Pargaonkar, Nikhil; Maurer, Laura E.; Ma, Sarina Grace Harris, Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use.
  78. Gao,Qingzhi; Gallop,Mark A.; Xiang,Jia Ning, Platinum-containing compounds exhibiting cytostatic activity, synthesis and methods of use.
  79. Jenkins, Thomas E., Polysubunit opioid prodrugs resistant to overdose and abuse.
  80. Jenkins, Thomas E., Polysubunit opioid prodrugs resistant to overdose and abuse.
  81. Gardner David L. (Bellville OH), Process of preparing microcapsules of lactides or lactide copolymers with glycolides and/or e 상세보기
  • Gallop, Mark A., Prodrugs of gaba analogs, compositions and uses thereof.
  • Beeley, Nathan R. F.; Coldren, Bret A.; Lust, Victor, Punctal plug containing drug formulation.
  • Coldren, Bret A.; Van Den Bekerom, Peter Paul Willem Leonard; De Laat, Antonius Wilhelmus Maria; Weekamp, Johannes Wilhelmus; Lust, Victor; Yewey, Gerald, Punctal plugs for controlled release of therapeutic agents.
  • Coldren, Bret A., Punctal plugs with directional release.
  • Hammond, Paula T.; Macdonald, Mara L., Self assembled films for protein and drug delivery applications.
  • Rhodes Alan (Ely GBX), Slow release formulation.
  • Andrew W. Buirge ; Paul J. Buscemi ; Paul H. Burmeister, Stent with collagen.
  • Bawa Rajan (Fairport NY) Ruscio Dominic V. (Rochester NY), Sustained release formulation containing an ion-exchange resin.
  • Mallick Sushanta, Sustained release ophthalmic formulation.
  • Singh,Onkar N.; Castillo,Ernesto J., Sustained release ophthalmic, otic and nasal suspension.
  • Jani Rajni (Fort Worth TX) Harris Robert G. (Fort Worth TX), Sustained release, comfort formulation for glaucoma therapy.
  • Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  • Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  • Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  • Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  • Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  • Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  • Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  • Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  • Liang, Likan; Wang, Hua; Bhatt, Padmanabh P.; Vieira, Michael L., Sustained-release formulations of topiramate.
  • Shell John W. (Hillsborough CA) Gale Robert M. (Mountain View CA), Topical composition containing steroid in two forms released independently from polymeric carrier.
  • Nangia, Avinash; Verma, Daya D.; Jacob, Jules, Topiramate compositions and methods of enhancing its bioavailability.
  • Barrett, Ronald W.; Canafax, Daniel M., Treating or preventing restless legs syndrome using prodrugs of GABA analogs.
  • Barrett, Ronald W., Treating urinary incontinence using prodrugs of GABA analogs.
  • 섹션별 컨텐츠 바로가기

    AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

    AI-Helper 아이콘
    AI-Helper
    안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
    ※ AI-Helper는 부적절한 답변을 할 수 있습니다.

    선택된 텍스트

    맨위로